Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Larimar Therapeutics Inc. buy melinda

Start price
€8.94
10.12.19 / 50%
Target price
€13.00
04.11.21
Performance (%)
16.33%
Price
€10.50
20.09.21
Summary
This prediction is currently active. The prediction currently has a performance of 16.33%. This prediction currently runs until 04.11.21. The prediction end date can be changed by melinda at any time. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Larimar Therapeutics Inc. -3.670% -3.670% -23.469%
iShares Core DAX® -3.980% -4.380% 14.751%
iShares Core MSCI World -2.656% -1.600% 32.080%
iShares Nasdaq 100 -2.956% -0.933% 39.152%
iShares S&P 500 -2.488% -2.254% 34.402%

According to melinda what are the pros and cons of Larimar Therapeutics Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by melinda for this prediction

In the thread Zafgen Inc. diskutieren

Buy Zafgen Inc.

Prediction Buy
Perf. (%) 16.33%
Target price 13.000
Change
Ends at 04.11.21

Kursziel gesetzt auf 13,0

Stopped prediction by melinda for Larimar Therapeutics Inc.

buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€54.88
07.02.19
€97.42
13.02.19
-11.83%
13.02.19

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€87.46
08.03.18
€97.42
25.06.18
16.58%
25.06.18

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€44.92
13.05.17
€54.12
14.11.17
-12.05%
14.11.17

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€78.15
07.04.16
€184.01
21.07.16
-54.46%
21.07.16

Could be worthwhile Investment >10% per year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€64.73
14.03.16
€81.18
04.04.16
26.76%
04.04.16

Could be worthwhile Investment >10% per year